Global Radiopharmaceuticals Market By Product Type (Diagnostic Radioisotopes, Therapeutic Radioisotopes) And By End-Users/Application (Oncology, Cardiology, Other) Global Market Share, Forecast Data, In-Depth Analysis, And Detailed Overview, and Forecast, 2013 – 2026

The Radiopharmaceuticals market report provides historical data along with future forecast and detailed analysis for Radiopharmaceuticals on a global and regional level. In this report, the global Radiopharmaceuticals market is valued at USD XX million in 2018 and is expected to reach USD XX million by the end of 2026, growing at a CAGR of XX% between 2019 and 2026. The study provides us with historical data along with forecast from 2019 to 2026. This research study helps the purchaser to understand the various drivers and restraints impacting Radiopharmaceuticals market during the forecast period. Additionally the study provides expected opportunities in Radiopharmaceuticals The Radiopharmaceuticals market research report provides a comprehensive study on production capacity, consumption, import and export for all major regions across the globe. The report covers an in depth description, competitive scenario, wide product portfolio of key vendors and business strategy adopted by competitors along with their SWOT analysis. To report various factors impacting the Radiopharmaceuticals the research study further incorporates Porter’s five forces model for the Radiopharmaceuticals market. The study encompasses a market attractiveness analysis, wherein each segment is benchmarked based on its market size, growth rate, and general attractiveness. The report is prepared by data received from in-house databases, secondary as well as primary research team comprising of various industry experts. The report has been prepared based on the synthesis, analysis, and interpretation of information about the global Radiopharmaceuticals market collected from specialized sources. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. Company overview, financial overview, product portfolio, new project launched, recent development analysis are the parameters included in the profile. The major manufacturer operating into Radiopharmaceuticals market include: Bracco Imaging Bayer Mallinckrodt Nordion Triad Isotopes Lantheus IBA Group GE Healthcare China Isotope & Radiation Jubilant Pharma Eli Lilly Advanced Accelerator Applications SIEMENS Dongcheng Navidea This report segments the global Radiopharmaceuticals market as follows: Global Radiopharmaceuticals Market: Type Segment Analysis Diagnostic Radioisotopes Therapeutic Radioisotopes Global Radiopharmaceuticals Market: Application Segment Analysis Oncology Cardiology Other Global Radiopharmaceuticals Market: Regional Analysis North America (U.S., Canada, Mexico) Europe (U.K., France, Germany, Spain, Italy, Central , Eastern Europe, CIS) Asia Pacific (China, Japan, South Korea, ASEAN, India, Rest of Asia Pacific) Latin America (Brazil, Rest of L.A.) Middle East And Africa(Turkey, GCC, Rest of Middle East)
Table of Contents 1 Market Overview 1.1 Radiopharmaceuticals Introduction 1.2 Market Analysis by Type 1.2.1 Diagnostic Radioisotopes 1.2.2 Therapeutic Radioisotopes 1.3 Market Analysis by Applications 1.3.1 Oncology 1.3.2 Cardiology 1.3.3 Other 1.4 Market Analysis by Regions 1.4.1 North America (United States, Canada and Mexico) 1.4.1.1 United States Market States and Outlook (2014-2024) 1.4.1.2 Canada Market States and Outlook (2014-2024) 1.4.1.3 Mexico Market States and Outlook (2014-2024) 1.4.2 Europe (Germany, France, UK, Russia and Italy) 1.4.2.1 Germany Market States and Outlook (2014-2024) 1.4.2.2 France Market States and Outlook (2014-2024) 1.4.2.3 UK Market States and Outlook (2014-2024) 1.4.2.4 Russia Market States and Outlook (2014-2024) 1.4.2.5 Italy Market States and Outlook (2014-2024) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 1.4.3.1 China Market States and Outlook (2014-2024) 1.4.3.2 Japan Market States and Outlook (2014-2024) 1.4.3.3 Korea Market States and Outlook (2014-2024) 1.4.3.4 India Market States and Outlook (2014-2024) 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024) 1.4.4 South America, Middle East and Africa 1.4.4.1 Brazil Market States and Outlook (2014-2024) 1.4.4.2 Egypt Market States and Outlook (2014-2024) 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024) 1.4.4.4 South Africa Market States and Outlook (2014-2024) 1.4.4.5 Turkey Market States and Outlook (2014-2024) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 Bracco Imaging 2.1.1 Business Overview 2.1.2 Radiopharmaceuticals Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 Bracco Imaging Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.2 Bayer 2.2.1 Business Overview 2.2.2 Radiopharmaceuticals Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 Bayer Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.3 Mallinckrodt 2.3.1 Business Overview 2.3.2 Radiopharmaceuticals Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 Mallinckrodt Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.4 Nordion 2.4.1 Business Overview 2.4.2 Radiopharmaceuticals Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 Nordion Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.5 Triad Isotopes 2.5.1 Business Overview 2.5.2 Radiopharmaceuticals Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 Triad Isotopes Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.6 Lantheus 2.6.1 Business Overview 2.6.2 Radiopharmaceuticals Type and Applications 2.6.2.1 Product A 2.6.2.2 Product B 2.6.3 Lantheus Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.7 IBA Group 2.7.1 Business Overview 2.7.2 Radiopharmaceuticals Type and Applications 2.7.2.1 Product A 2.7.2.2 Product B 2.7.3 IBA Group Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.8 GE Healthcare 2.8.1 Business Overview 2.8.2 Radiopharmaceuticals Type and Applications 2.8.2.1 Product A 2.8.2.2 Product B 2.8.3 GE Healthcare Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.9 China Isotope & Radiation 2.9.1 Business Overview 2.9.2 Radiopharmaceuticals Type and Applications 2.9.2.1 Product A 2.9.2.2 Product B 2.9.3 China Isotope & Radiation Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.10 Jubilant Pharma 2.10.1 Business Overview 2.10.2 Radiopharmaceuticals Type and Applications 2.10.2.1 Product A 2.10.2.2 Product B 2.10.3 Jubilant Pharma Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.11 Eli Lilly 2.11.1 Business Overview 2.11.2 Radiopharmaceuticals Type and Applications 2.11.2.1 Product A 2.11.2.2 Product B 2.11.3 Eli Lilly Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.12 Advanced Accelerator Applications 2.12.1 Business Overview 2.12.2 Radiopharmaceuticals Type and Applications 2.12.2.1 Product A 2.12.2.2 Product B 2.12.3 Advanced Accelerator Applications Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.13 SIEMENS 2.13.1 Business Overview 2.13.2 Radiopharmaceuticals Type and Applications 2.13.2.1 Product A 2.13.2.2 Product B 2.13.3 SIEMENS Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.14 Dongcheng 2.14.1 Business Overview 2.14.2 Radiopharmaceuticals Type and Applications 2.14.2.1 Product A 2.14.2.2 Product B 2.14.3 Dongcheng Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.15 Navidea 2.15.1 Business Overview 2.15.2 Radiopharmaceuticals Type and Applications 2.15.2.1 Product A 2.15.2.2 Product B 2.15.3 Navidea Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 3 Global Radiopharmaceuticals Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018) 3.1 Global Radiopharmaceuticals Sales and Market Share by Manufacturer (2017-2018) 3.2 Global Radiopharmaceuticals Revenue and Market Share by Manufacturer (2017-2018) 3.3 Market Concentration Rate 3.3.1 Top 3 Radiopharmaceuticals Manufacturer Market Share in 2018 3.3.2 Top 6 Radiopharmaceuticals Manufacturer Market Share in 2018 3.4 Market Competition Trend 4 Global Radiopharmaceuticals Market Analysis by Regions 4.1 Global Radiopharmaceuticals Sales, Revenue and Market Share by Regions 4.1.1 Global Radiopharmaceuticals Sales and Market Share by Regions (2014-2019) 4.1.2 Global Radiopharmaceuticals Revenue and Market Share by Regions (2014-2019) 4.2 North America Radiopharmaceuticals Sales and Growth Rate (2014-2019) 4.3 Europe Radiopharmaceuticals Sales and Growth Rate (2014-2019) 4.4 Asia-Pacific Radiopharmaceuticals Sales and Growth Rate (2014-2019) 4.5 South America Radiopharmaceuticals Sales and Growth Rate (2014-2019) 4.6 Middle East and Africa Radiopharmaceuticals Sales and Growth Rate (2014-2019) 5 North America Radiopharmaceuticals by Country 5.1 North America Radiopharmaceuticals Sales, Revenue and Market Share by Country 5.1.1 North America Radiopharmaceuticals Sales and Market Share by Country (2014-2019) 5.1.2 North America Radiopharmaceuticals Revenue and Market Share by Country (2014-2019) 5.2 United States Radiopharmaceuticals Sales and Growth Rate (2014-2019) 5.3 Canada Radiopharmaceuticals Sales and Growth Rate (2014-2019) 5.4 Mexico Radiopharmaceuticals Sales and Growth Rate (2014-2019) 6 Europe Radiopharmaceuticals by Country 6.1 Europe Radiopharmaceuticals Sales, Revenue and Market Share by Country 6.1.1 Europe Radiopharmaceuticals Sales and Market Share by Country (2014-2019) 6.1.2 Europe Radiopharmaceuticals Revenue and Market Share by Country (2014-2019) 6.2 Germany Radiopharmaceuticals Sales and Growth Rate (2014-2019) 6.3 UK Radiopharmaceuticals Sales and Growth Rate (2014-2019) 6.4 France Radiopharmaceuticals Sales and Growth Rate (2014-2019) 6.5 Russia Radiopharmaceuticals Sales and Growth Rate (2014-2019) 6.6 Italy Radiopharmaceuticals Sales and Growth Rate (2014-2019) 7 Asia-Pacific Radiopharmaceuticals by Country 7.1 Asia-Pacific Radiopharmaceuticals Sales, Revenue and Market Share by Country 7.1.1 Asia-Pacific Radiopharmaceuticals Sales and Market Share by Country (2014-2019) 7.1.2 Asia-Pacific Radiopharmaceuticals Revenue and Market Share by Country (2014-2019) 7.2 China Radiopharmaceuticals Sales and Growth Rate (2014-2019) 7.3 Japan Radiopharmaceuticals Sales and Growth Rate (2014-2019) 7.4 Korea Radiopharmaceuticals Sales and Growth Rate (2014-2019) 7.5 India Radiopharmaceuticals Sales and Growth Rate (2014-2019) 7.6 Southeast Asia Radiopharmaceuticals Sales and Growth Rate (2014-2019) 8 South America Radiopharmaceuticals by Country 8.1 South America Radiopharmaceuticals Sales, Revenue and Market Share by Country 8.1.1 South America Radiopharmaceuticals Sales and Market Share by Country (2014-2019) 8.1.2 South America Radiopharmaceuticals Revenue and Market Share by Country (2014-2019) 8.2 Brazil Radiopharmaceuticals Sales and Growth Rate (2014-2019) 8.3 Argentina Radiopharmaceuticals Sales and Growth Rate (2014-2019) 8.4 Colombia Radiopharmaceuticals Sales and Growth Rate (2014-2019) 9 Middle East and Africa Radiopharmaceuticals by Countries 9.1 Middle East and Africa Radiopharmaceuticals Sales, Revenue and Market Share by Country 9.1.1 Middle East and Africa Radiopharmaceuticals Sales and Market Share by Country (2014-2019) 9.1.2 Middle East and Africa Radiopharmaceuticals Revenue and Market Share by Country (2014-2019) 9.2 Saudi Arabia Radiopharmaceuticals Sales and Growth Rate (2014-2019) 9.3 Turkey Radiopharmaceuticals Sales and Growth Rate (2014-2019) 9.4 Egypt Radiopharmaceuticals Sales and Growth Rate (2014-2019) 9.5 Nigeria Radiopharmaceuticals Sales and Growth Rate (2014-2019) 9.6 South Africa Radiopharmaceuticals Sales and Growth Rate (2014-2019) 10 Global Radiopharmaceuticals Market Segment by Type 10.1 Global Radiopharmaceuticals Sales, Revenue and Market Share by Type (2014-2019) 10.1.1 Global Radiopharmaceuticals Sales and Market Share by Type (2014-2019) 10.1.2 Global Radiopharmaceuticals Revenue and Market Share by Type (2014-2019) 10.2 Diagnostic Radioisotopes Sales Growth and Price 10.2.1 Global Diagnostic Radioisotopes Sales Growth (2014-2019) 10.2.2 Global Diagnostic Radioisotopes Price (2014-2019) 10.3 Therapeutic Radioisotopes Sales Growth and Price 10.3.1 Global Therapeutic Radioisotopes Sales Growth (2014-2019) 10.3.2 Global Therapeutic Radioisotopes Price (2014-2019) 11 Global Radiopharmaceuticals Market Segment by Application 11.1 Global Radiopharmaceuticals Sales Market Share by Application (2014-2019) 11.2 Oncology Sales Growth (2014-2019) 11.3 Cardiology Sales Growth (2014-2019) 11.4 Other Sales Growth (2014-2019) 12 Radiopharmaceuticals Market Forecast (2019-2024) 12.1 Global Radiopharmaceuticals Sales, Revenue and Growth Rate (2019-2024) 12.2 Radiopharmaceuticals Market Forecast by Regions (2019-2024) 12.2.1 North America Radiopharmaceuticals Market Forecast (2019-2024) 12.2.2 Europe Radiopharmaceuticals Market Forecast (2019-2024) 12.2.3 Asia-Pacific Radiopharmaceuticals Market Forecast (2019-2024) 12.2.4 South America Radiopharmaceuticals Market Forecast (2019-2024) 12.2.5 Middle East and Africa Radiopharmaceuticals Market Forecast (2019-2024) 12.3 Radiopharmaceuticals Market Forecast by Type (2019-2024) 12.3.1 Global Radiopharmaceuticals Sales Forecast by Type (2019-2024) 12.3.2 Global Radiopharmaceuticals Market Share Forecast by Type (2019-2024) 12.4 Radiopharmaceuticals Market Forecast by Application (2019-2024) 12.4.1 Global Radiopharmaceuticals Sales Forecast by Application (2019-2024) 12.4.2 Global Radiopharmaceuticals Market Share Forecast by Application (2019-2024) 13 Sales Channel, Distributors, Traders and Dealers 13.1 Sales Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.1.3 Marketing Channel Future Trend 13.2 Distributors, Traders and Dealers 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology 15.2 Data Source
1662

1943

OUR CLIENT